NFKB1 and Cerebral ischemia: It had been reported that salidroside exhibited the inhibitory effect on the inflammatory cytokine production in LPS-charged BV2 cell [3], in order to have a new insight into the potential neuroprotective functions peculiar to salidroside against cerebral ischemia; we further used the LPS-induced BV2 cell model to investigate the antichemotaxic effects of salidroside and the possible involvement of the NF-κB and MAPK signaling pathway.